spondylitis, Crohn's disease, and hepatitis C. He has a history of child abuse and treated chronic depression. He had an episode of postoperative delirium but no other prior psychotic symptoms. His 9 daily medications included prednisone, ranitidine, sertraline, and high dosages of morphine.
Because of its deliriogenic effects, Mr W's morphine was decreased from 360 mg daily to 300 mg daily. He was begun on olanzepine 2.5 mg daily, which was increased to 10 mg daily within 3 days. He remained on the higher dosage of olanzepine for 1 week with no change in his symptoms or agitation. At this point, he met the "1-month" criteria for delusional disorder, somatic type. He was switched to pimozide 2 mg daily. Within 10 days, complete resolution of his symptoms occurred. He was discharged home on pimozide, which was tapered to 1 mg after 1 month. At 6 weeks, he had no recurrent symptoms. The pimozide will be discontinued at 2 months.
Discussion
Pimozide therapy was first reported to be beneficial for somatic delusions in 5 patients in 1975 (7) . Several small, noncontrolled studies have reported its benefits, which include recovery from delusions of parasitosis in up to 90% of patients (1) .
Newer studies suggest that atypical antipsychotics are equally effective (2) . The serotonergic activity of atypicals is suggested to have the additional benefit of reducing the obsessive-compulsive and self-mutilatory features of somatic delusions (2) .
Case reports have found response to risperidone in various somatic delusional disorders (4) (5) (6) . In a 1997 study, treatment with risperidone eliminated symptoms in 3 patients with long histories of delusions of parasitosis who did not respond to haloperidol or pimozide (3) . Recently, treatment with low-dosage olanzapine led to complete resolution of symptoms in a case of delusions of infestation (8) . Most patients in these studies presented with long-standing histories, having experienced delusions for months to years.
In our case, the older, typical neuroleptic pimozide was effective in treating the newonset delusion of infestation. More rigorous study into the benefits of treatment with pimozide vs the newer neuroleptics would be useful, not only for treating somatic delusions but also for patients presenting with early symptoms.
Gabapentin Treatment for Premature Ejaculation
Dear Editor: Premature or rapid ejaculation (PE) is the commonest sexual dysfunction in men, with a reported prevalence of up to 39% in the general male population and an even greater prevalence in the first-degree male relatives of men with PE (1). The essential feature of PE is persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it (2) . However, no standardized method of assessing PE has been defined, and research criteria have included the following measures: reduced latency to ejaculation after intromission or reduced intravaginal latency time (IELT), limited control over the occurrence of ejaculation, concern about ejaculating too soon, dissatisfaction with the inability to select the moment of ejaculation, and the occurrence of antiportal ejaculation.
PE is postulated to be a neurobiological phenomenon involving primarily a disturbance of serotonin 5-HT 2C and 5-HT 1A receptor function. However, ejaculation in male humans is a complex physiological process: other central inputs and neurotransmitters, such as dopamine, and autonomic and somatic reflexes dependent on alpha 1-adrenergic and cholinergic neurons, respectively , all play a role (1).
Consequently, numerous medications known to influence different receptors are reported to delay ejaculation. These include serotonergic drugs such as selective serotonin reuptake inhibitors (SSRIs) and clomipramine, alpha-adrenergic antagonists such as prazosin, and benzodiazepines such as clonazepam (3) . I report the successful use of gabapentin, an anticonvulsant, in the treatment of PE.
Case Report
Mr X, aged 40 years, has a DSM-IV diagnosis of PE, lifelong situational type attributable to combined factors. Stop-pause, stop-squeeze coital alignment techniques and the use of a condom with topical anesthetic (5% lidocaine) were associated with limited response. Conventional pharmacotherapies were also minimally effective and had doselimiting side effects. Treatment with paroxetine, sertraline, and to a lesser extent, venlafaxine was associated with restless legs, gastrointestinal disturbance, headache, decreased libido, and erectile dysfunction. Trazodone and lorazepam caused sedation and cognitive slowing, while bupropion accelerated ejaculation. Mr X had previously found that alcohol produced satisfactory ejaculatory delay with no loss of erectile capacity, but clearly this was not a feasible regular option. A trial of gabapentin 300 mg taken 1 to 2 hours prior to intercourse resulted in a similar effect with no side effects. Higher doses of 600 mg resulted in further retardation of ejaculation but also in somnolence.
The mechanism of action of gabapentin is not clear, but it is believed to increase GABA through increased GABA release and synthesis and to decrease the release of monoamine neurotransmitters (4). Since benzodiazepines and alcohol can also delay ejaculation and are also GABAergic through a direct action on GABA-A receptors, it is postulated that gabapentin's effect on ejaculation may be mediated via its action on GABA. Further, anorgasmia has been described in a male patient with bipolar disorder receiving gabapentin (5) .
Currently, there are no specific treatments for PE, although dapoxetine, an SSRI-type drug with a short half-life, is undergoing clinical trials. Thus, gabapentin merits further consideration, particularly in those men for whom other therapies are ineffective or poorly tolerated.
Pierre Chue, FRCPC Edmonton, Alberta

Suspected Propranolol-Induced Delirium
Dear Editor: Propranolol has been used for many years in internal medicine, neurology, and psychiatry. Surprisingly, only a few case reports of propranolol-induced delirium have been published to date, according to Medline and Toxline databases. In 1979, Kuhr reported a case of prolonged delirium with propanolol use (1) . Two cases of delirium, the first associated with combined propranolol and maprotiline and the second associated with combined propranolol, benztropine, and fluphenazine decanoate, have also been described (2, 3) . In 1994, Chen reported 3 cases of elderly patients with recent cerebral infarction and preexisting brain dysfunction who were receiving 30 to 60 mg of propranolol daily (4). Watanabe found adjunctive propranolol, scopolamine, and (or) flurazepam before or after surgery to be the strongest predictor of delirium in postoperative orthopedic patients (5) . It remains uncertain whether propranolol-induced delirium is very rare or just not reported.
Case Report
A man aged 74 years, a retired joiner, was first admitted to the psychogeriatric unit owing to increasing aggressiveness that was first noticed 3 years earlier. Family members reported paranoid delusions. On admission, he was oriented in time and place. His Mini-Mental State Examination (MMSE) score was 21. Blood counts, bilirubin, aspartate transaminase, alanine aminotransferase, alkaline phosphatase, albumin, potassium, sodium, calcium, glucose, creatinine, urea, and thyroid hormones were within normal limits. ECG revealed sinus arrhythmia. Because he suffered from prostatic carcinoma, the patient had been treated with ciproterone 200 mg daily for 4 years. Olanzapine 5 mg daily was started for treatment of his paranoid delusions. Propranolol had been suggested earlier by a neurologist to alleviate essential tremor, but the patient never started this treatment. On the fifth day after admission, propranolol was started at 40 mg daily and gradually increased to 120 mg daily, when delirium was noticed at night. The patient became sleepless, restless, and disoriented and showed impaired consciousness. During the day, he was tired but without impaired consciousness. On the third day, propranolol was discontinued. Symptoms of delirium disappeared the next day. A decrease in diastolic blood pressure of only 10 mm Hg was measured during the treatment with propranolol.
It is well known that delirium is more often a consequence of multiple etiologic factors than a consequence of a single one. Delirium may be attributed to central beta blockade; in our case, however, preexisting cognitive decline, old age, and other physical illnesses may have predisposed the patient to propranolol toxicity. That said, the time of beginning and resolving the delirium strongly suggest propranolol as the main etiologic factor. The patient's tremor was later successfully alleviated with gabapentin.
